Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Contraception
FDA approval granted to make Essure at lower-cost site in Mexico
May 13th, 2004
Conceptus, Inc., (CPTS) announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company to begin manufacturing the Essure System at UTI Venusa, Ltd., in Ciudad Juarez, Mexico. Conceptus expects that this change will result in a significant decrease in manufacturing costs, which would enable Conceptus to become profitable in 2005. "This approval caps the year-long project to bring the Venusa facility on line to manufacture Essure," said William Dippel, VP of manufacturing and R&D for Conceptus. "We are already shifting production to this facility, and should see an immediate savings in manufacturing costs." ...
Source: Women's Health Weekly (2004-05-13)
|
